RESUMO
INTRODUCTION: Pediatric tracheostomy indications have changed over the last 30 years, from acute and transient pro cedures secondary to airway obstruction to programmed tracheostomies indicated due to the need for chronic use of mechanical ventilation (MV). OBJECTIVE: To describe indications and morbidity associated with pediatric tracheostomies during a ten-year period. PATIENTS AND METHODS: Descrip tive study. Clinical records review of discharged patients (< 15 years old) tracheostomized during their hospital stay between 2005 and 2015. Demographic and clinical variables were evaluated before and after tracheostomy, stay in intensive care unit, age at the time of the tracheostomy, indication of tracheostomy, early complications (< 7 days), late complications (> 7 days), and mortality. RESULTS: 59 children with tracheostomy were analyzed, 36 (59%) tracheostomies were performed in children under 6 months, and 39 (60%) in males. 23 (39%) had a confirmed or under study genopathy and 25 (42%) had congenital heart disease. The main indications for tracheostomy were 58% secondary to airway disease and 42% due to chronic use of MV. Within the airway disease group, subglottic steno sis, vocal cord paralysis, and tracheobronchomalacia were the principal reasons for indication, and in the group of chronic use of MV, the main causes were bronchopulmonary dysplasia and chronic lung disease. We did not find tracheostomy-related mortality. 89% of the patients were discharged with tracheostomy and 59% with chronic use of MV. The probability of being discharged with a tracheos tomy was higher in younger patients while the chronic use of MV at discharge was higher in patients with a greater number of extubation failures before tracheostomy. CONCLUSION: Tracheostomy is a safe procedure in children, where the predominant causes of indication are airway disease and the need for chronic use of MV. Most children with tracheostomies are discharged with tracheostomy and chronic use of MV. Younger children, those with difficult weaning, confirmed or suspected ge nopathy, or special health needs are at greater risk of needing tracheostomy and chronic use of MV.
Assuntos
Respiração Artificial , Traqueostomia/efeitos adversos , Adolescente , Criança , Feminino , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Pediátrica , Tempo de Internação , Masculino , Estudos Retrospectivos , Traqueobroncomalácia/epidemiologia , Paralisia das Pregas Vocais/epidemiologiaRESUMO
Tracheobronchomalacia refers to the presence of trachea and bronchi with soft, collapsible walls. Its incidence has been reported from 1:1500 to 1:2500. It can be congenital or acquired. This disease ranges from mild to life threatening. A high clinical suspicion is required for diagnosis, which needs to be confirmed endoscopically. Depending on severity, treatment can include from physical therapy and antibiotics to mechanical ventilation, surgery and tracheostomy, and is based on expert opinion and case series. Prognosis is usually good, with tendency to spontaneous resolution near the 2d year of life.
Traquebroncomalacia se refiere a la presencia de tráquea y/o bronquios cuya pared es blanda y tiene tendencia al colapso. Se ha reportado una incidencia entre 1:1.500 a 1:2.500. Puede ser congénita o adquirida. La severidad de los síntomas varía desde leve a incluso riesgo vital y muerte. El diagnóstico requiere una alta sospecha clínica y confirmación endoscópica. El tratamiento está basado en opiniones de expertos y series clínicas y varía según la severidad de los síntomas desde kinesioterapia y antibióticos en los casos más leves hasta ventilación mecánica, traqueostomía y cirugía en los más severos. El pronóstico en general es bueno con tendencia a la resolución espontánea aproximadamente a los 2 años de vida.